Curasight is active in the pharmaceutical industry. The company specializes in research and development of various drug candidates. The product portfolio includes, for example, research and development within Positron Emission Tomography (PET) and related ancillary services. The business is operating with the largest presence within Scandinavia. Curasight is headquartered in Copenhagen.

Quotes for Curasight A/S

Created with Highstock 6.0.7CloseTraded Volume10. mar17. mar24. mar31. mar7. apr21. apr28. apr5. maj12. maj19. maj2. jun02468050T100T150T200T

Right Now

+/-
0.26
%
9,89%
Latest
2.89
High
2.89
Low
2.68
Volume
11 559
Turnover (DKK)
32 019
Market Value (MDKK)
61,1
Time (Latest trade)

Board

CEO

  • Ulrich Krasilnikoff

Chairperson of the Board

  • Kirsten Drejer

Board

  • Andreas Kjær
  • Charlotte Vedel
  • Lars Trolle
  • Ulrich Krasilnikoff

News

Show More

News agencies

Show More

Analysis

Videos

Curasight - Providing answers for cancer patients

Curasight - Providing answers for cancer patients

Curasight - Providing answers for cancer patients

Curasight - Providing answers for cancer patients

Curasight - Providing answers for cancer patients

Largest Owners

Name Capital % Votes % Date
Andreas Kjær 30,24 30,24 2023-12-31
UK Curacap ApS 19,46 19,46 2024-06-14
Carsten Haagen Nielsen 12,11 12,11 2023-12-31
Jacob Madsen 4,57 4,57 2023-12-31
Lars Trolle 2,95 2,95 2023-12-31
Chr. Olesen Holding A/S 2,01 2,01 2024-06-14
Gerhard Dal 0,33 0,33 2024-06-14
Per Falholt 0,33 0,33 2023-12-31
Johan Stein 0,20 0,20 2024-06-14
Charlotte Vedel 0,20 0,20 2023-12-31
Holdings by Modular Finance AB. Compiled and processed data from various sources, including VP Securities, Morningstar and The Danish Financial Supervisory Authority (Finanstilsynet)

Insider trading

NameTransaction DateTypeInstrumentAmountPriceValueCurrency
Hanne Damgaard Jensen2022-09-01Buy TransactionCurasight 7 60018,62141 488,8SEK
Hanne Damgaard Jensen2022-06-10Buy TransactionCurasight 10 79919,51210 645,7SEK
Hanne Damgaard Jensen2022-06-09Buy TransactionCurasight 5 60119,75110 626,9SEK
Kirsten Drejer2021-12-13Buy TransactionCurasight 3 88643,61169 484,1SEK
Milou Holding ApS2021-09-20en-USCurasight 18 22823,63430 794,4SEK
Lars Trolle2021-09-20en-USCurasight 3 03823,6371 799,1SEK
Per Falholt2021-09-20en-USCurasight 30 38023,63717 990,7SEK
Krasilnikoff Holding 1 Aps2021-09-20en-USCurasight 3 03823,6371 799,1SEK
Krasilnikoff Holding 1 Aps2021-09-20en-USCurasight 3 03823,6371 799,1SEK
Charlotte Vedel2021-09-20en-USCurasight 6 07623,63143 598,1SEK
Andreas Kjær2021-09-20en-USCurasight 3 03823,6371 799,1SEK
*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

Key Numbers

2025-03-312024-12-312024-12-312024-09-302024-06-302024-03-312023-12-31
Number of months that the report spans Q1 3 Months2024Q4 3 MonthsQ3 3 MonthsQ2 3 MonthsQ1 3 Months2023
Total revenue MDKK0.000.000.000.000.000.000.00
Earnings before interest and tax MDKK-6.21-40.37-11.92-8.10-10.97-9.38-33.21
Profit before tax MDKK-6.58-42.34-12.34-8.52-12.11-9.37-33.22
Net profit MDKK-5.20-38.21-12.33-7.15-10.74-7.99-26.17
Earnings per share DKK-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Dividend per share DKK0.000.00
Equity MDKK2.516.346.3413.3112.6523.3931.38
Fixed assets MDKK0.000.000.000.000.000.000.00
Intangible assets MDKK6.626.836.837.037.237.447.64
Current assets MDKK10.9915.4415.4418.7021.5620.0931.05
Total asset MDKK17.6622.3122.3125.7828.8527.5738.74
Long term liabilities MDKK0.000.000.000.000.000.000.00
Current liabilities MDKK15.1515.9815.9812.4716.194.187.36
Number of shares DKK21.1521.1521.1520.6819.8919.8919.89
*Compiled data from Millistream

Upcoming reports

  • 2025-08-28 Delårsrapport 2025-Q2

  • 2025-11-27 Delårsrapport 2025-Q3

Annual reports, prospectus etc.